文章(zhang)來源：華潤（集團(tuan)）有限公司 發布時間：2009-08-26
華潤(run)集團(tuan)旗下三九(jiu)醫藥股份有限公(gong)司發布2008年(nian)(nian)半年(nian)(nian)度報告，公(gong)司實(shi)現營業(ye)收入(ru)19.10億(yi)(yi)元(yuan)，同(tong)比(bi)增(zeng)(zeng)長(chang)(chang)19.94％；營業(ye)利潤(run)2.77億(yi)(yi)元(yuan)，同(tong)比(bi)增(zeng)(zeng)長(chang)(chang)116.55％；歸屬(shu)(shu)于(yu)母(mu)公(gong)司的凈利潤(run)為2.09億(yi)(yi)元(yuan)，同(tong)比(bi)增(zeng)(zeng)長(chang)(chang)122.95％；實(shi)現每股收益0.21元(yuan)。公(gong)告還稱，經財(cai)務部門初步(bu)測算(suan)，預計(ji)今年(nian)(nian)前九(jiu)個月，實(shi)現的歸屬(shu)(shu)于(yu)母(mu)公(gong)司所有者的凈利潤(run)與上年(nian)(nian)同(tong)期相(xiang)比(bi)增(zeng)(zeng)長(chang)(chang)100%-150%。
今年(nian)上半年(nian)，三(san)九醫(yi)藥股份公司醫(yi)藥工業收(shou)入同(tong)(tong)比(bi)增(zeng)(zeng)長23.72%，其中OTC銷售(shou)(shou)額同(tong)(tong)比(bi)增(zeng)(zeng)長14%，中藥處(chu)方(fang)藥銷售(shou)(shou)額同(tong)(tong)比(bi)增(zeng)(zeng)長50%，抗生素及(ji)原料藥銷售(shou)(shou)額同(tong)(tong)比(bi)增(zeng)(zeng)長66%，延(yan)續(xu)了較(jiao)快(kuai)的增(zeng)(zeng)長勢頭，免煎中藥銷售(shou)(shou)額同(tong)(tong)比(bi)增(zeng)(zeng)長55%。產品方(fang)面(mian)，主打產品感(gan)(gan)冒靈(ling)銷售(shou)(shou)同(tong)(tong)比(bi)增(zeng)(zeng)長26%，達(da)到(dao)2.65億(yi)(yi)元；皮(pi)(pi)炎(yan)平軟膏銷售(shou)(shou)達(da)到(dao)2.46億(yi)(yi)元，同(tong)(tong)比(bi)增(zeng)(zeng)長12.60%，參(can)附(fu)及(ji)生脈銷售(shou)(shou)分別增(zeng)(zeng)長52%及(ji)230%，三(san)九皮(pi)(pi)炎(yan)平、三(san)九胃泰保持平穩(wen)；新(xin)產品小(xiao)兒感(gan)(gan)冒靈(ling)、復(fu)方(fang)氨酚烷胺、無水頭孢唑林鈉(na)等增(zeng)(zeng)長快(kuai)速。